Ibrolipim T7832
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Ibrolipim attenuates high glucose-induced endothelial dysfunction in cultured human umbilical vein endothelial cells via PI3K/Akt pathway.
CAS nr:
133208-93-2
Purity:
98%
Molecular Weight:
451,25
SMILES:
CCOP(=O)(Cc1ccc(C(=O)Nc2ccc(Br)cc2C#N)cc1)OCC
Formula:
Br1C19H20N2O4P1
Pathway:
GPCR/G Protein
Target:
LPL Receptor
